Navigation Links
CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G

short term income and recurring revenue streams from a successful product launch in the future.

Regulatory strategy

CeNeS preferred strategy is for a partner to be involved in the key decisions regarding regulatory filing strategies both in Europe and in United States. The strategy in the USA is clear. The strong data obtained from the most recent Phase III study validates the proposed product profile of M6G and strengthens CeNeS position with potential North American partners. Registration could be achieved in the USA in 2009 after conducting two Phase III studies to the requirements of the FDA. It is important to note that the quality and robustness of the clinical data produced by the current study significantly reduces the risk for the development of M6G by enabling optimal trial design and the selection of endpoints in the remaining Phase III studies.

In Europe the narrow failure to achieve statistical significance with the second chosen primary endpoint of incidence and severity of nausea (p=0.052 not p<0.050) offers three options:

1) Pursue a filing application in certain European countries with the comprehensive clinical data package that CeNeS has assembled. 2) Further strengthen the European package by conducting an additional European Phase III study which would complete in 2008 with product filing in 2009. 3) Use the USA Phase III trials to support the European application, potentially with a global partner.

CeNeS will continue to discuss the above strategies with regulatory consultants and potential partners.

Neil Clark, Chief Executive of CeNeS commented "The ongoing analysis of the Phase III results further confirms our belief in the excellent potential of M6G as a novel product for post- operative pain. The quality and breadth of the data contained in this large study supports M6G's anticipated product profile.

The potential for reduced anti-emetic drug costs combined with the reduction in medical assi
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Independent publication supports the profile of CeNeS phase II compound, CNS 5161
3. CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
(Date:5/26/2015)... -- Haemonetics Corporation (NYSE: HAE ) announced today that ... present at The East Coast IDEAS Investor Conference in ... , 2015 at 2:30pm Eastern time.  ... webcast at: http://www.wsw.com/webcast/threepa16/hae About ... global healthcare company dedicated to providing innovative blood management ...
(Date:5/26/2015)... -- Depomed, Inc. (NASDAQ: DEPO ) today announced that ... The 2015 Jefferies Healthcare Conference in New ... for 3:00 pm EDT (12:00 noon PDT) Tuesday, June 2, ... Conference in New York City.  The presentation at the JMP ... Wednesday, June 24, 2015. Both presentations will be ...
(Date:5/26/2015)... , England and PITTSBURGH , May ... a leading global pharmaceutical company, today announced that Mylan ... the Bernstein Strategic Decisions Conference, Friday, May 29, 2015 ... can access a live webcast of the presentation via ... http://mylan.com/investors . An archived version will also be available ...
Breaking Medicine Technology:Depomed To Present At Healthcare Conferences In June 2
... 2007 - Cytogen,Corporation (NASDAQ: CYTO) today announced ... at upcoming major medical meetings. The,data will ... QUADRAMET(R),(samarium Sm-153 lexidronam injection) in combination settings ... from prostate,cancer and multiple myeloma, as well ...
... of,In-Segment Late Loss, Non-Inferiority in Major Secondary Endpoint,of Target ... in the SPIRIT III U.S. Trial -, ABBOTT PARK, ... Abbott's SPIRIT III U.S. pivotal clinical,trial at the of ... following key results: , , -- ...
Cached Medicine Technology:New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 2New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 3New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 4New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 5Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 2Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 3Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 4Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 5
(Date:5/26/2015)... Octo Consulting Group (Octo), an award-winning ... to the federal marketplace, has named Gaurav “GP” Pal ... this newly created role, Pal will be responsible for ... computing, big data, and digital services. , “We’re excited ... we continue to bring clients new and innovative solutions ...
(Date:5/26/2015)... May 26, 2015 Relias Learning ... for the health and human services market, announces expansion ... demand. After strong attendance and participation in 2014, they ... give their annual user conference an exciting new facelift. ... to come together and discuss best practices, share their ...
(Date:5/26/2015)... Pasadena, CA (PRWEB) May 26, 2015 ... is now offering complimentary dental cleanings with cosmetic treatments. ... , Cosmetic Dentistry , “We are committed ... giving you cutting-edge technology, outstanding customer service and a ... not only to change your smiles but to change ...
(Date:5/26/2015)... National Prevention Week , National Prevention Week ... supported by the Substance Abuse and Mental Health Services ... and action about, substance abuse as well as mental ... encouraged to join in promoting prevention strategies, in educating ... in building community partnerships. , The Voice of One, ...
(Date:5/26/2015)... York, NY (PRWEB) May 26, 2015 Award-winning ... for a good cause. "The photography show will connect viewers ... in their lives.” For the last five years, Raul has ... to convey the notion that we are not bounded by ... a language spoken in Raul’s native country, Bolivia. The photo ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group (Octo) Appoints Gaurav “GP” Pal as Vice President of Technology Strategy and Cloud Solutions 2Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:A Photographer & Two Educational Organiazations Join to Make a Difference in Our Youth 2
... Time" a Valuable Present: Peake, WASHINGTON, Dec. 21 ... volunteers who remember our nation,s,veterans, especially those hospitalized in ... "Some of our patients will be unable to ... B. Peake, Secretary of Veterans Affairs. "The,good cheer and ...
... research suggests , FRIDAY, Dec. 21 (HealthDay News) -- Treating ... concludes a University of Pennsylvania School of Medicine study in ... , It found that providing depression care management to older ... over five years by about 50 percent. , "Depression is ...
... for ambulatory care ... ... Cardiac Science,Corporation, (Nasdaq: CSCX ), a leading provider of ... of its HeartCentrix(R) ECG informatics software with Greenway,Medical Technology,s PrimeSuite(R) ...
... Milk Processors and, Bally Total Fitness to Shape Up ... ... SILVER SPRING, Md., Dec. 21 Discovery Health,s fifth,annual NATIONAL ... biggest and best year yet, with online registration beginning on,December ...
... costs of providing comprehensive screening and diagnostic services to ... or cervical cancer for treatment. Dr. Donatus U. Ekwueme ... Health Promotion at the Centers for Disease Control and ... cost of screening a woman for breast cancer was ...
... 20 ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA ), ... Drug,Application (NDA) to the U.S. Food and Drug ... seeking approval for Xibrom QD,as a treatment for ... (bromfenac ophthalmic solution), Xibrom is a topical ...
Cached Medicine News:Health News:VA Salutes Volunteers' Spreading Holiday Cheer 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 4Health News:Discovery Health's Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle 2Health News:Discovery Health's Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle 3Health News:Study determines costs of breast and cervical cancer detection among low-income women 2Health News:ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily) 2
... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
... Unparalleled Comfort Pick one of our pipettors ... the trigger and ejector positionsright where they should ... are ergonomically designed to help avoid repetitive stress ... Productivity In The Palm Of Your Hand ...
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... The total ergonomic solution and best value ... feather touch action and ultra lightweight design ... tip ejection with long, lever tip ejector ... , Accepts universal tips or for greater ...
Medicine Products: